News | October 30, 2025
Novartis India posts Q2 FY26 PAT at Rs. 24.22 Cr
Novartis India has reported total income of Rs. 99.73 crore during the period ended September 30, 2025
Novartis India has reported total income of Rs. 99.73 crore during the period ended September 30, 2025
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Dr Reddys Laboratories has reported total income of Rs. 8,805.1 crore during the period ended September 30, 2025
Laurus Labs has reported total income of Rs. 1,680.43 crore during the period ended September 30, 2025
Bajaj Healthcare has reported total income of Rs. 149.56 crore during the period ended September 30, 2025
RPG Life Sciences has reported total income of Rs. 186.22 crore during the period ended September 30, 2025
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
SMS Pharmaceuticals has reported total income of Rs. 196.64 crores during the period ended June 30, 2025
Subscribe To Our Newsletter & Stay Updated
